journal article·2025-01

Enhanced Real‐Time Monitoring of Catalytic Therapy Efficacy with Dual‐Channel MRI and Fluorescent Platform

Huiyi Liu, Yibo Guo, Jingxia Lv, Juntao Xu, Qingpeng Zhang, Guoqiang Guan, Cheng Zhang, Chang Lu, Qiufang Gong, Chao Liang, Dong Xu, Guosheng Song

Advanced Functional Materials· Volume 35· Issue 2
Publisher page

Abstract

Abstract Catalytic therapies, such as chemodynamic therapy and ferroptosis, harness the tumor microenvironment to enhance the specificity and penetration of treatments, thus improving targeted tumor therapy. Despite these advancements, treatment effectiveness varies due to individual differences, making precise monitoring of drug activity and dosage essential to optimize therapy. Traditional imaging strategies, which monitor metal ion release or reactive oxygen species production, frequently fail to well correlate with therapeutic outcome. Herein, this study have developed an integrated self‐monitoring catalytic therapy platform that combines palladium‐ and manganese‐based nanoparticles (PdMn NPs) with caspase‐3 activated probe (Casp probe). Dual‐channel MRI and fluorescent probe, responsive to both low pH and caspase‐3 activity, significantly enhances the accuracy of real‐time therapeutic evaluations, allowing for early reporting treatment response (in 6 h), earlier than tumor volume reduction (8 days). This approach improves the assessment of therapeutic outcomes and aligns with the shift toward individualized cancer treatment protocols.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced MRI Techniques and Applications · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Chemo/Bio‐Sensing and Chemometrics College of Chemistry and Chemical Engineering Hunan University Changsha Hunan 410082 P. R. China

Institute for Advanced Research Department of Neurosurgery Cixi Biomedical Research Institute Affiliated Cixi Hospital Wenzhou Medical University Ningbo Zhejiang 315300 P. R. China

Department of Diagnostic Ultrasound Imaging & Interventional Therapy Zhejiang Cancer Hospital Hangzhou Institute of Medicine (HIM) Chinese Academy of Sciences Hangzhou Zhejiang 310022 P. R. China

Wenling Institute of Big Data and Artificial Intelligence in Medicine Center of Intelligent Diagnosis and Therapy (Taizhou) Taizhou Campus of Zhejiang Cancer Hospital (Taizhou Cancer Hospital) Taizhou Key Laboratory of Minimally Invasive Interventional Therapy & Artificial Intelligence Taizhou Zhejiang 317502 P. R. China

Funding

National Natural Science Foundation of China · National Key Research and Development Program of China · Natural Science Foundation of Ningbo Municipality · China Postdoctoral Science Foundation

References (51)

Show source-provided references
1. 10.1038/s41392-024-01808-110.1038/s41392-024-01808-1 ↗
2. 10.3322/caac.2176310.3322/caac.21763 ↗
3. 10.1016/j.ccr.2024.21578610.1016/j.ccr.2024.215786 ↗
4. 10.1038/s41392-023-01536-y10.1038/s41392-023-01536-y ↗
5. 10.1038/s41392-024-01851-y10.1038/s41392-024-01851-y ↗
6. 10.1016/j.ccr.2024.21579610.1016/j.ccr.2024.215796 ↗
7. 10.1016/j.nantod.2017.06.01010.1016/j.nantod.2017.06.010 ↗
8. 10.1016/j.addr.2022.11444710.1016/j.addr.2022.114447 ↗
9. 10.1039/D3TB00464C10.1039/D3TB00464C ↗
10. 10.1021/acsnano.3c0185610.1021/acsnano.3c01856 ↗
11. 10.1002/anie.20220048010.1002/anie.202200480 ↗
12. 10.1002/smll.20220404710.1002/smll.202204047 ↗
13. 10.1002/anie.20200778610.1002/anie.202007786 ↗
14. 10.1002/adfm.20210024310.1002/adfm.202100243 ↗
15. 10.1002/adma.20221087610.1002/adma.202210876 ↗
16. 10.1002/adma.20210705410.1002/adma.202107054 ↗
17. 10.1002/anie.20221041510.1002/anie.202210415 ↗
18. 10.1021/acsnano.1c0917110.1021/acsnano.1c09171 ↗
19. 10.1002/anie.20180566410.1002/anie.201805664 ↗
20. 10.1007/s40820-024-01399-010.1007/s40820-024-01399-0 ↗
21. 10.1021/acsnano.3c0344310.1021/acsnano.3c03443 ↗
22. 10.1002/cac2.1225010.1002/cac2.12250 ↗
23. 10.1016/j.chempr.2022.03.00910.1016/j.chempr.2022.03.009 ↗
24. 10.1038/s41580-024-00703-510.1038/s41580-024-00703-5 ↗
25. 10.1016/j.nantod.2023.10209510.1016/j.nantod.2023.102095 ↗
26. 10.1016/j.ccr.2020.21358110.1016/j.ccr.2020.213581 ↗
27. 10.1002/anie.20231815510.1002/anie.202318155 ↗
28. 10.1021/acs.nanolett.9b0355610.1021/acs.nanolett.9b03556 ↗
29. 10.1038/s41575-020-0352-210.1038/s41575-020-0352-2 ↗
30. 10.1016/j.bbcan.2022.18868110.1016/j.bbcan.2022.188681 ↗
31. 10.1038/s41568-019-0121-010.1038/s41568-019-0121-0 ↗
32. 10.1016/j.addr.2023.11479310.1016/j.addr.2023.114793 ↗
33. 10.1016/j.ajps.2021.10.00310.1016/j.ajps.2021.10.003 ↗
34. 10.1002/adma.20180274810.1002/adma.201802748 ↗
35. 10.1002/adhm.20210197110.1002/adhm.202101971 ↗
36. 10.1039/D1SC05482A10.1039/D1SC05482A ↗
37. 10.1016/j.chempr.2020.06.02410.1016/j.chempr.2020.06.024 ↗
38. 10.1016/j.ccr.2024.21575510.1016/j.ccr.2024.215755 ↗
39. 10.1038/cdd.2014.21610.1038/cdd.2014.216 ↗
40. 10.1038/s41571-020-0341-y10.1038/s41571-020-0341-y ↗
41. 10.1016/j.cell.2017.02.03110.1016/j.cell.2017.02.031 ↗
42. 10.1038/3503771010.1038/35037710 ↗
43. 10.1021/acs.analchem.2c0034010.1021/acs.analchem.2c00340 ↗
44. 10.1021/acs.analchem.2c0009810.1021/acs.analchem.2c00098 ↗
45. 10.1021/acs.analchem.3c0138710.1021/acs.analchem.3c01387 ↗
46. 10.1021/acs.nanolett.3c0178710.1021/acs.nanolett.3c01787 ↗
47. 10.1039/C5CS00541H10.1039/C5CS00541H ↗
48. 10.1038/s41551-021-00687-z10.1038/s41551-021-00687-z ↗
49. 10.26599/NBE.2023.929004710.26599/NBE.2023.9290047 ↗
50. 10.26599/NBE.2024.929006010.26599/NBE.2024.9290060 ↗
51. 10.26599/NBE.2024.929006110.26599/NBE.2024.9290061 ↗